Heavy Metals
EDTA Chelation Therapy
EDTA (EthyleneDiamineTetraAcetic Acid) is a synthetic amino acid related to vinegar. EDTA was developed by the Germans in 1931 to reverse heavy-metal poisoning from the ingestion of lead, mercury, aluminum, cadmium, and more.
A search through the medical literature of the past will turn up no less than 1,554 mentions of chelation therapy. Chelation therapy is not a new treatment—it is one of the best guarded secrets that is known for health improvement.
Chelation therapy will remove excessive levels of 13 minerals from your body—lead, mercury, nickel, cadmium, and aluminum—all toxic minerals. It also will remove some good minerals from your body as well—such as chromium, copper, iron, magnesium, manganese, and calcium. It is important to take mineral supplements to counteract this while on chelation therapy.
In an 18-year study, Dr. Walter Blumer of Switzerland used EDTA to reduce the incidence of heart disease and cancer in his patients by 80 percent.
How does it work?
Chelation can be used to treat heavy metal toxification, heart disease, and in some cases even cancer.
EDTA is known to be a calcium-blocking agent and a potent coronary vasodilator. EDTA can bind or chelate calcium, as well as other minerals in the body. It removes calcium particles deposited in arterial wall plaques and atheromas. In addition, EDTA blocks the slow calcium currents in the arterial wall, resulting in arterial vasodilation.
Probably the major underlying condition leading to cardiovascular disease is atherosclerosis, also known as hardening of the arteries. In time, this degenerative disease can narrow or block arteries in the heart, brain, and other parts of the body. It may begin early in life. The linings of the arteries become thickened and roughened by deposits of fat, cholesterol, fibrin (a clotting material), cellular debris, and calcium.
As this buildup on the inner walls becomes hard and thick, arteries lose their ability to expand and contract. The blood moves with difficulty through the narrowed artery channels. This makes it easier for a clot to form that will block the channel (lumen) and deprive the heart, brain, and other organs of the necessary blood supply.
To review precisely what chelation is, consider the following: the electromagnetic attraction of fats and proteins for divalent calcium that has wandered through the injuries in blood vessel walls is the same process that enables EDTA to remove calcium and fat from the plaque that occludes the vessel. A study of over six hundred human aortas has demonstrated alterations in the elastic tissue with accumulations of calcium prior to the deposition of fat and cholesterol. (Blumenthal, 1944).
When calcium (or other divalent metals such as lead, mercury, cadmium, aluminum, etc.) is chelated by EDTA, the original electromagnetic attraction is lost, and the fatty debris is dissolved by circulating blood and metabolized. The calcium-EDTA molecule, now inactive and non-toxic, is carried by the blood until it passes through the kidneys. It then is removed from the body via the urine.
The solid sticky plaque goes into solution and is harmlessly removed. By this unique mechanism, dangerous solids are converted to a liquid, then transported away to be eliminated. This is a natural, normal phenomenon of body chemistry.
Norman E. Clarke, Sr., M.D., a cardiologist at Providence Hospital in Detroit, was the first American to discover the many beneficial effects of EDTA chelation. When he treated battery factory workers for lead poisoning, they reported relief of their symptoms of chest pain (angina), arthritis, intermittent claudication (severe leg pain due to plugged arteries in the legs), as well as their symptoms of lead poisoning.
The Russians use chelation therapy as the second most common treatment for arteriosclerotic artery disease. EDTA chelation is administered with great success for blood vessel disease, stroke, senility, diabetes, kidney diseases, and other degenerative diseases in Germany, Switzerland, Mexico, and Canada, to name just a few countries.
Chelation Therapy and High Blood Pressure
People with greatly elevated blood pressure commonly have symptoms of dizziness, shortness of breath, headache, and blurred vision. In mild to moderate blood pressure elevation, there may be no symptoms. The diastolic or resting heart pressure is the second number of the blood pressure reading. In younger patients with diastolic pressures of 110 millimeters of mercury or higher, headaches in the morning are common.
As the pressure continues its abnormal rise, death or damage to the heart, brain, or kidneys is likely. The heart will enlarge, kidneys begin to fail, and uremia is present. Stroke is common.
These patients commonly range in age from forty to seventy. Their blood pressure is above 110 millimeters mercury diastolic. Systolic pressures (the first number of the blood pressure reading) range from 130 to 170 or more. In a 35-year-old man with a normal blood pressure of 120/80, the risk of death over the next twenty years would double if his pressure were 142/90. That risk increases 2.2 times at 142/95. At 152/95, the twenty year mortality risk is 2.5 times
Some critics have complained that treatment with EDTA is not "permanent." These uninformed experts would know, if they had any experience with the treatment, that the results are probably more permanent than any other vascular treatment utilized in this country today. Once the occluding slag and sludge is removed from the inside walls of the arteries, they can carry blood efficiently once more and elasticity returns. In other words, ischemic atherosclerosis is reversed.
Tissues, organs, and cells downstream of the formerly plugged artery can now obtain the nutrients and oxygen that were once denied. These cells which were once dormant, or partially dormant, can now revive and carry on their normal metabolic chemistry. Toxins and waste products that have not been properly removed due to inadequate circulation are eliminated as the perfusion normalizes.
Exerpt from Dr. E.W. McDonagh